UK says vaccine manufacturing is 'lumpy' but still on course for targets
Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said on Monday. Ciara Lee reports
UP NEXT
UP NEXT
-
Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says
Reuters
-
Australia asks European Commission to review Italy's vaccine block
Reuters
-
Alabama extends mask mandate for a month, breaking with Texas, Mississippi
Reuters
-
Obesity a driving factor in COVID-19 deaths, global report finds
Reuters
-
Germany to ease COVID-19 curbs, ramp up vaccinations
Reuters
-
Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
Reuters
-
Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
Reuters
-
New U.S. COVID-19 cases hit plateau after steep drops
Reuters
-
Global COVID-19 infections up for first time in seven weeks, WHO says
Reuters
-
U.S. downplays possibility of sharing COVID-19 vaccines with Mexico
Reuters
-
J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators
Reuters
-
More than 20 million in Britain get first COVID-19 vaccine dose
Reuters
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
Reuters
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
Reuters
-
Exclusive: Mexico's president expected to ask Biden to share U.S. vaccines, say sources
Reuters
-
"Things are tenuous," U.S. CDC says as downward trend in COVID-19 cases stalls
Reuters